|
2026
|
G/S
|
Pharmaceutical preparations for use against immune and inflammatory diseases |
|
|
G/S
|
Ophthalmic surgery devices and instruments for controlled sub-retinal delivery of pharmaceutical,... |
|
|
G/S
|
Downloadable computer software for monitoring manufacturing processes in the pharmaceutical industry |
|
|
G/S
|
Pharmaceutical preparations for oncology |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological diseases |
|
|
Invention
|
Flt3 ligand fusion proteins and methods of use.
The invention provides an effectorless immunoglo... |
|
|
Invention
|
Dual specific antibodies.
The invention provides dual specific antibodies and methods of making ... |
|
|
Invention
|
Semi-automated high-throughput mid-scale protein expression methods.
The present disclosure rela... |
|
|
Invention
|
Method and medicament for treating cancer unresponsive to pd-1/pd-l1 signaling inhibitor.
The pr... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular, metabolic and renal diseases and... |
|
|
G/S
|
Pharmaceutical preparations for use in neuroscience |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy. |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy |
|
|
Invention
|
Lubricated fluid exchange needle for enhanced performance of refillable implantable ocular drug d... |
|
|
Invention
|
Enhanced septum retention for implanted ocular delivery systems.
An ophthalmic drug delivery dev... |
|
|
G/S
|
IC 010: Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devi... |
|
|
G/S
|
pharmaceutical preparations for use in oncology |
|
|
Invention
|
Methods of producing polypeptides using a cell line resistant to apoptosis.
Provided herein are ... |
|
|
Invention
|
Diagnostic and therapeutic methods for cancer.
Provided herein are diagnostic and therapeutic me... |
|
|
Invention
|
Biomolecule fitness inference for variant nomination using machine learning with directed evoluti... |
|
|
Invention
|
Compositions and methods for treating multiple sclerosis.
The present invention relates to metho... |
|
|
Invention
|
Anti-trop2 bispecific antibodies. The present disclosure provides TROP2xEGFR bispecific antibodie... |
|
2025
|
Invention
|
Sequence-based machine learning enabled protein molecule design with protein structure representa... |
|
|
Invention
|
In situ detection of barcodes.
The current disclosure provides a method suitable for detecting b... |
|
|
Invention
|
Ire1 degrader compounds and methods of use. Provided here are IRE1 degrader compounds comprising ... |
|
|
Invention
|
Methods and compositions for assessing immune response to lipid compositions. The disclosure rela... |
|
|
Invention
|
Methods and compositions for treating systemic lupus erythematosus (sle) with mosunetuzumab.
Dis... |
|
|
Invention
|
Machine learning enabled region-specific lesion segmentation.
A method may include determining, ... |
|
|
Invention
|
Method for simultaneous quantification of lipid and nucleic acid components in lipid nanoparticle... |
|
|
Invention
|
Automated feature extraction for diabetic retinopathy (dr) lesions and/or features using deep lea... |
|
|
Invention
|
Retinal predictions using predicted future optical coherence tomography (oct) images. A method an... |
|
|
Invention
|
Macrophage signatures for diagnostic and therapeutic methods for lymphoma.
The present invention... |
|
|
Invention
|
Machine learning enabled gene based prediction of intercellular interactions. A training dataset ... |
|
|
Invention
|
Anti-cd79b antibodies and immunoconjugates and methods of use.
The present invention is directed... |
|
|
G/S
|
Downloadable computer software for health and medical data analysis and downloadable computer sof... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for early detection of cancer;... |
|
|
Invention
|
Methods and systems for analyzing cell surface proteins. e.g.e.g., by mass spectrometry. In certa... |
|
|
Invention
|
Machine learning-enabled analysis of protein sequences and generation of protein sequences therew... |
|
|
Invention
|
Eukaryotic cell media. This disclosure relates to eukaryotic cell culture media useful in the pro... |
|
|
Invention
|
Methods and compositions for single-cell functional genomics. Aspects of the technology relate to... |
|
|
Invention
|
Treatment of steatotic liver disease associated with metabolic dysfunction. The present disclosur... |
|
|
Invention
|
Treatment of steatotic liver disease associated with metabolic dysfunction.
The present disclosu... |
|
|
Invention
|
Afucosylation modification.
The present application relates to methods of producing a protein in... |
|
|
Invention
|
Afucosylation modification. The present application relates to methods of producing a protein in ... |
|
|
Invention
|
Multi-objective optimization for molecule design.
A plurality of molecule designs may be generat... |
|
|
Invention
|
Methods of treating multiple sclerosis with cd19-cd20 dual car-t cells. The present disclosure pr... |
|
|
Invention
|
Methods of treating lupus with cd19-cd20 dual car-t cells. e.g.e.g. highly active, severe, treatm... |
|
|
Invention
|
Managing clinical trial progression using machine learning-based data.
Systems and methods for m... |
|
|
Invention
|
Subcutaneous dosing of anti-cd20/anti-cd3 bispecific antibodies.
The present invention relates t... |
|
|
Invention
|
Anti-interleukin-23 receptor vhh antibodies and uses thereof. Interleukin-23 receptor (IL23R) VHH... |
|
|
Invention
|
Machine learning enabled treatment response analysis using a cell density based computational pat... |
|
|
Invention
|
Therapy for the treatment of non-hodgkin lymphoma. Provided herein are methods of treating and/or... |
|
|
Invention
|
Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab.
The presen... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical pre... |
|
|
Invention
|
Anti-cd3 antibodies and methods of use.
The invention provides anti-cluster of differentiation 3... |
|
|
Invention
|
Pharmaceutical compositions comprising akt protein kinase inhibitors.
The present invention rela... |
|
|
Invention
|
Fusions with proteases and uses thereof.
Provided herein are fusion proteins that involve an ant... |
|
|
Invention
|
Cysteine engineered antibodies and conjugates.
Cysteine engineered antibodies comprising a free ... |
|
|
Invention
|
Pre-filled syringe with embedded filter.
Apparatus and methods for filtering syringe fluid conte... |
|
|
Invention
|
Methods of treating her2-positive metastatic breast cancer.
Methods of treating patients having ... |
|
|
Invention
|
E3 ligase family functions and interactions.
Provided herein are methods of treating cancers, in... |
|
|
G/S
|
Educational services, namely, providing presentations in the field of oncology products and disea... |
|
|
G/S
|
Pharmaceutical preparations, applied subcutaneously, for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in neurological disorders including Alzheimer's |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheim... |
|
|
Invention
|
Pharmaceutical compound, salts thereof, formulations thereof, and methods of making and using sam... |
|
|
G/S
|
Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices |
|
|
G/S
|
Software products for healthcare, monitoring, screening, assessment, diagnosis, and intervention,... |
|
2024
|
G/S
|
Pharmaceutical preparations for use in immunology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology, neurology and immunology |
|
|
G/S
|
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological diseases |
|
2023
|
Invention
|
Oxazepine compounds comprising a 6-aza moiety and uses thereof.
Provided herein are oxazepinyl c... |
|
2016
|
Invention
|
Method for treating multiple sclerosis. The present invention concerns methods for treating multi... |
